Chromosomal aberrations in prostate cancer xenografts detected by comparative genomic hybridization
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
A major problem in studying prostate cancer has been the lack of model systems because of the difficulties in growing prostate cancer cells in vitro. Recently, however, several human prostate cancer xenografts, grown in immune‐deficient mice, have been established. Here, we characterized 13 such xenografts (LuCaP 23.8, 23.12, 35, 41, 49, 58, 69, 70, 73, LAPC‐4AD, LAPC‐4AI, LAPC‐9AD, and LAPC‐9AI) as well as one prostate cancer cell line (22Rv1) derived from a xenograft for chromosomal alterations by comparative genomic hybridization and a modification of multicolor fluorescence in situ hybridization. On average, the xenografts contained 13 (range 5–28) aberrations, 5 (1–13) gains, and 8 (1–15) losses, per case. The chromosome arms that most often contained losses were 2q, 5q, 6q, 8p, 13q, and 18q, and gains were 7q, 8q, and Xq. The same regions were previously shown to be often altered in advanced prostate carcinomas in patients. The androgen‐dependent and corresponding androgen‐independent sublines of LAPC‐4 and LAPC‐9 shared all genetic alterations, suggesting that the transition of the growth from androgen dependency to independence does not involve major chromosomal aberrations in these two models. In conclusion, the identified genetic aberrations lay the groundwork for further detailed genetic analyses of these xenografts. © 2002 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
In vivo amplification of the androgen receptor gene and progression of human prostate cancer
Visakorpi, T., Hyytinen, E., Koivisto, P., Tanner, M., Keinänen, R., Palmberg, C., Palotie, A., Tammela, T., Isola, J., & Kallioniemi, O.-P. (1995) · Nature Genetics · doi:10.1038/ng0495-401 · Cited by 1,484 · cited 5×
“…established from untreated prostate cancers showed fewer aberrations than did the xenografts established from hormone-refractory tumors, in concordance with our earlier findings indicating that the number of chromosomal alterations is higher in hormone-refractory tumors (Visakorpi et al., 1995b).”
BackgroundMethodResultInfluentialSelf-citationCharacterization of chromosomal abnormalities in prostate cancer cell lines by spectral karyotyping
Pan, Y., Kytölä, S., Farnebo, F., Wang, N., Lui, W. O., Nupponen, N., Isola, J., Visakorpi, T., Bergerheim, U. S. R., & Larsson, C. (1999) · Cytogenetic and Genome Research · doi:10.1159/000015432 · Cited by 63
Self-citation
Cited by
Molecular determinants of resistance to antiandrogen therapy
Chen, C. D., Welsbie, D. S., Tran, C., Baek, S. H., Chen, R., Vessella, R., Rosenfeld, M. G., & Sawyers, C. L. (2004) · Nature Medicine · doi:10.1038/nm972 · Cited by 2,278
“But can this simple model for hormone-refractory progression be reconciled with previous work implicating other mechanisms? AR gene amplification could result in increased androgen receptor levels, but this occurs in a minority of patients and cannot be invoked as the explanation for our xenograft findings, as there w…”
BackgroundSelf-citationPatient-derived tumour xenografts as models for oncology drug development
Tentler, J. J., Tan, A. C., Weekes, C. D., Jimeno, A., Leong, S., Pitts, T. M., Arcaroli, J. J., Messersmith, W. A., & Eckhardt, S. G. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2012.61 · Cited by 1,277
MicroRNA Expression Profiling in Prostate Cancer
Porkka, K. P., Pfeiffer, M. J., Waltering, K. K., Vessella, R. L., Tammela, T. L. J., & Visakorpi, T. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0533 · Cited by 899
Self-citationReprogramming transcription by distinct classes of enhancers functionally defined by eRNA
Wang, D., Garcia-Bassets, I., Benner, C., Li, W., Su, X., Zhou, Y., Qiu, J., Liu, W., Kaikkonen, M. U., Ohgi, K. A., et al. (2011) · Nature · doi:10.1038/nature10006 · Cited by 827
Patient-derived xenograft (PDX) models, applications and challenges in cancer research
Abdolahi, S., Ghazvinian, Z., Muhammadnejad, S., Saleh, M., Asadzadeh Aghdaei, H., & Baghaei, K. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03405-8 · Cited by 326
Metadata
- Authors
- Laitinen, S., Karhu, R., Sawyers, C. L., Vessella, R. L., & Visakorpi, T.
- Venue
- Genes, Chromosomes and Cancer
- Publisher
- Wiley
- Published
- 2002-07-26
- Volume
- 35
- Issue
- 1
- Pages
- 66-73
- ISSN
- 1045-2257 (ISSN-L)
- 1098-2264
- OpenAlex
- W2064007516
- Cited by
- 45
- References
- 2
- FWCI
- 2.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Chromosomal aberrations in prostate cancer xenografts detected by comparative genomic hybridization. https://app.cochat.ai/papers/10.1002/gcc.10097
- The paper
- Laitinen, S., Karhu, R., Sawyers, C. L., Vessella, R. L., & Visakorpi, T. (2002). Chromosomal aberrations in prostate cancer xenografts detected by comparative genomic hybridization. Genes, Chromosomes and Cancer. https://doi.org/10.1002/gcc.10097
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.